Synergy timing: Because the two peptides have different half-lives (30 min vs 2h), co-administration produces a sustained GH-release window during the period of overlapping receptor activation, peaking 15-30 minutes post-injection
WADA lists IGF-1 and all its analogs, including IGF-1 LR3, on the Prohibited List under peptide hormones, growth factors, related substances, and mimetics (class S2)
This magic and powerful antioxidant is not just your wellness trend
This includes anyone with an active skin infection, rash, or breakoutlike acne, eczema, or even a bad sunburnin the area you want to treat
Patients should avoid purchasing peptides from unregulated online research chemical suppliers